Development Level

Tbio 34 | 10,625
Tchem 10 | 1,890
Tclin 6 | 602
Tdark 1 | 7,003

IMPC Term

decreased bone mineral content 3 | 157
embryonic lethality prior to o... 3 | 148
decreased body weight 2 | 174
decreased lean body mass 2 | 195
decreased total body fat amoun... 2 | 186
embryonic lethality prior to t... 2 | 187
increased circulating chloride... 2 | 43
increased lean body mass 2 | 107
preweaning lethality, complete... 2 | 633
abnormal behavior 1 | 226
abnormal bone structure 1 | 131
abnormal coping response 1 | 12
abnormal embryo size 1 | 112
abnormal eyelid aperture 1 | 3
abnormal heart morphology 1 | 51
abnormal lens morphology 1 | 73
abnormal neural tube closure 1 | 37
abnormal placenta size 1 | 10
cataract 1 | 26
decreased body length 1 | 108
decreased circulating HDL chol... 1 | 77
decreased circulating alanine ... 1 | 53
decreased circulating choleste... 1 | 85
decreased effector memory CD8-... 1 | 24
decreased exploration in new e... 1 | 9
decreased grip strength 1 | 123
decreased mean corpuscular hem... 1 | 34
decreased mean corpuscular vol... 1 | 50
decreased neutrophil cell numb... 1 | 37
enlarged heart 1 | 111
enlarged lymph nodes 1 | 27
hypoactivity 1 | 89
increased bone mineral content 1 | 92
increased circulating HDL chol... 1 | 63
increased circulating phosphat... 1 | 24
increased mean corpuscular hem... 1 | 93
pale yolk sac 1 | 12
pallor 1 | 13
polydactyly 1 | 22
prenatal lethality prior to he... 1 | 64
preweaning lethality, incomple... 1 | 260
tremors 1 | 34

Disease

ovarian cancer 29 | 8,484
psoriasis 27 | 6,685
Cancer 26 | 2,346
glioblastoma 26 | 5,572
osteosarcoma 24 | 7,933
medulloblastoma, large-cell 22 | 6,234
atypical teratoid / rhabdoid tumor 18 | 4,369
lung cancer 18 | 4,466
intraductal papillary-mucinous adenoma (IPMA) 17 | 2,956
lung carcinoma 17 | 2,844
Breast cancer 16 | 3,094
malignant mesothelioma 16 | 3,162
pilocytic astrocytoma 15 | 3,086
intraductal papillary-mucinous neoplasm (IPMN) 14 | 3,289
pancreatic cancer 14 | 2,300
Carcinoma 13 | 2,147
non-small cell lung cancer 13 | 2,798
pediatric high grade glioma 13 | 2,712
diabetes mellitus 12 | 1,663
cystic fibrosis 11 | 1,665
ependymoma 11 | 2,514
lung adenocarcinoma 11 | 2,713
nasopharyngeal carcinoma 11 | 1,056
oligodendroglioma 11 | 2,849
ulcerative colitis 11 | 2,087
astrocytoma 10 | 1,493
juvenile dermatomyositis 10 | 1,189
Alzheimer's disease 9 | 644
acute quadriplegic myopathy 9 | 1,157
astrocytic glioma 9 | 2,241
cutaneous lupus erythematosus 9 | 1,056
dermatomyositis 9 | 933
primitive neuroectodermal tumor 9 | 3,031
subependymal giant cell astrocytoma 9 | 2,287
Anemia 8 | 252
Duchenne muscular dystrophy 8 | 602
Multiple myeloma 8 | 1,327
Rheumatoid Arthritis 8 | 1,160
breast carcinoma 8 | 1,614
group 3 medulloblastoma 8 | 2,254
interstitial cystitis 8 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,988
invasive ductal carcinoma 8 | 2,950
Arthritis 7 | 248
Down syndrome 7 | 548
Kidney disease 7 | 396
adult high grade glioma 7 | 2,148
esophageal adenocarcinoma 7 | 737
group 4 medulloblastoma 7 | 1,875
pancreatic carcinoma 7 | 567
pancreatic ductal adenocarcinoma liver metastasis 7 | 1,795
pituitary cancer 7 | 1,972
posterior fossa group A ependymoma 7 | 1,511
Amyotrophic Lateral Sclerosis 6 | 431
Atopic dermatitis 6 | 944
Barrett's esophagus 6 | 183
Cerebrovascular disease 6 | 231
Lung disease 6 | 132
Neurodegenerative disease 6 | 383
Obesity 6 | 616
Schizophrenia 6 | 501
active Crohn's disease 6 | 918
autosomal dominant Emery-Dreifuss muscular dystrophy 6 | 499
colon cancer 6 | 1,475
gastric carcinoma 6 | 832
hepatocellular carcinoma 6 | 532
primary Sjogren syndrome 6 | 789
tuberculosis 6 | 1,557
Adenocarcinoma 5 | 115
Atherosclerosis 5 | 275
Bladder Neoplasm 5 | 109
Colorectal Neoplasms 5 | 217
Diarrhea 5 | 155
Hepatitis C 5 | 90
Hypersensitivity reaction type II disease 5 | 235
Liver carcinoma 5 | 217
Melanoma 5 | 261
Myocardial Ischemia 5 | 169
Osteoporosis 5 | 257
Pick disease 5 | 1,893
Polycystic Ovary Syndrome 5 | 332
Prostatic Neoplasms 5 | 471
Squamous cell carcinoma of esophagus 5 | 82
Stomach Neoplasms 5 | 282
Vascular disease 5 | 281
Waldenstrons macroglobulinemia 5 | 765
acute myeloid leukemia 5 | 780
adrenocortical carcinoma 5 | 1,427
medulloblastoma 5 | 1,524
mucosa-associated lymphoid tissue lymphoma 5 | 480
progressive supranuclear palsy 5 | 674
tuberculosis and treatment for 6 months 5 | 686
Coronary artery disease 4 | 240
Hypertension 4 | 287
Hypertensive disease 4 | 193
Inflammatory bowel disease 4 | 142
Multiple Sclerosis 4 | 498
ductal carcinoma in situ 4 | 1,745
primary pancreatic ductal adenocarcinoma 4 | 1,271
spina bifida 4 | 1,064

Tissue

Blood and immune system 50 | 17,995
Cardiovascular System 50 | 17,958
Digestive Tract 50 | 18,473
Endocrine System 50 | 18,512
Female tissues 50 | 18,647
Liver and Pancreas 50 | 18,136
Male tissues 50 | 17,969
Nervous System 50 | 18,561
Skin and soft tissues 50 | 18,115
Urinary Tract 50 | 18,444
Respiratory system 49 | 17,484

Target Family

Non-IDG 24 | 11,971
Enzyme 19 | 4,146
Transcription Factor 4 | 1,400
Ion Channel 2 | 341
Epigenetic 1 | 242
Transporter 1 | 473

Grant Application

5P41RR001646-29 51 | 51
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Endoplasmin HSP90B1 Tchem Non-IDG -2.72785 604.5 748
Serine/arginine repetitive matrix protein 2 SRRM2 Tbio Non-IDG -1.90106 71.6 51
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Serotransferrin TF Tchem Non-IDG -4.13136 13124.3 952
Transferrin receptor protein 1 TFRC Tbio Non-IDG -3.39868 2437.0 1167
Amphiphysin AMPH Tbio Non-IDG -2.64544 426.2 341
Prostaglandin G/H synthase 2 PTGS2 Tclin Enzyme -4.03668 12041.6 648
Dual specificity protein phosphatase 1 DUSP1 Tchem Enzyme -2.84900 767.9 361
Calnexin CANX Tbio Non-IDG -2.84021 679.1 521
Spectrin alpha chain, erythrocytic 1 SPTA1 Tbio Non-IDG -2.88963 796.7 82